Skip to main content

Dr. Booth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Booth's full profile

Already have an account?

  • Office

    1051 Loftis Blvd
    Ste 100
    Newport News, VA 23606
    Phone+1 757-873-9400
    Fax+1 757-873-9420

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1976 - 1976
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Radiology-Diagnostic, 1974 - 1976
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1971 - 1974
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1971

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1971 - 2024
  • MD State Medical License
    MD State Medical License 1982 - 1986
  • WI State Medical License
    WI State Medical License 1972 - 1976
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Press Mentions

  • Vigil Neuroscience Completes $90 Million Series B Financing to Advance a Pipeline of Microglia-Targeted Medicines to Treat Rare and Common Neurodegenerative Diseases
    Vigil Neuroscience Completes $90 Million Series B Financing to Advance a Pipeline of Microglia-Targeted Medicines to Treat Rare and Common Neurodegenerative DiseasesAugust 18th, 2021
  • 10 Twitter Accounts to Follow for Biotech Updates
    10 Twitter Accounts to Follow for Biotech UpdatesJanuary 29th, 2021
  • Vigil Neuroscience Launches with $50 Million in Financing to Develop Microglia-Based Therapeutics for Neurodegenerative Diseases
    Vigil Neuroscience Launches with $50 Million in Financing to Develop Microglia-Based Therapeutics for Neurodegenerative DiseasesDecember 8th, 2020
  • Join now to see all

Professional Memberships